Bearing Point Capital, LLC Astrazeneca PLC Transaction History
Bearing Point Capital, LLC
- $470 Billion
- Q1 2025
A detailed history of Bearing Point Capital, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Bearing Point Capital, LLC holds 13,022 shares of AZN stock, worth $918,571. This represents 0.2% of its overall portfolio holdings.
Number of Shares
13,022
Previous 11,407
14.16%
Holding current value
$918,571
Previous $747 Million
28.06%
% of portfolio
0.2%
Previous 0.16%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,428Shares Held
504MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.03 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.87 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.51 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.25 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.21 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $219B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...